Replies to post #374940 on Amarin Corp Plc (AMRN)

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[Birdbrain Ideas]

Thanks Raf. Those numbers are actually encouraging. If we could ever get two or three weeks in a row showing growth like this, we could call it a trend. Don't know if we might take a hit next week because of the religious holidays. Hope not.

[couldbebetter]

Raf, Something must be wrong...Those numbers look good!

[lizzy241]

raf thanks for taking time from your get away to post scripts. This is the first sign in months that possibly GV's lack of insurance coverage may be the beginning of a turnaround in V scripts?
I think Hikma may have to restate their 2 qtr est????
Hope you and your family have a great vacation.
Happy Easter and Happy Passover to all.

[Bolio98]

Thanks raf. Any theories on why AMRN kicked the generics ass this week?

CVS kicking in?

I get a laugh out of Hickma falling off a cliff, yet THEY are the ones being sued for infringement and THEY would be responsible for the treble damages.

AMRN should appeal the dismissal and Hikma should settle in a heartbeat. IMO.

[rafunrafun]

Scripts for week ending April 15, 2022 - Holidays.

Drug Industry TRx: -2.6% w/w; +9.2% y/y

Vascepa
TRx 69,653; -4.2% (-3,019) w/w; -16.9% y/y
NRx 32,340; -5.1% (-1,756) w/w; -16.6% y/y
Ref 37,312; -3.3% (-1,263) w/w; -17.2% y/y

Lovaza (Generic & Brand)
TRx 61,486; -1.8% (-1,124) w/w; +1.1% y/y
NRx 30,783; -4.2% (-1,351) w/w; +1.6% y/y
Ref 30,703; +0.7% (+227) w/w; +0.6% y/y

Generic Vascepa
TRx 31,001; +3.4% (+1,033) w/w; As % of total V: 30.8%
NRx 16,487; +4.0% (+633) w/w; As % of total V: 33.8%
Ref 14,514; +2.8% (+400) w/w; As % of total V: 29.0%

Generic Vascepa by Manufacturer
Hikma - TRx 6,351; (-510) w/w; Generic share 20.5%; Total V share 6.3%
Reddy - TRx 13,524; (+657) w/w; Generic share 43.6%; Total V share 13.4%
Apotex - TRx 11,127; (+887) w/w; Generic share 35.9%; Total V share 11.1%

Vascepa + Generic Vascepa
TRx 100,654; -1.9% (-1,986) w/w; +8.3% y/y
NRx 48,828; -2.2% (-1,123) w/w; +11.3% y/y
Ref 51,826; -1.6% (-863) w/w; +5.6% y/y